Social anxiety disorder: Psychobiological and evolutionary underpinnings

CNS Spectrums

Volumn 12, Issue 11, 2007, Pages 806-809

  Stein, Dan J ^a,b   Vythilingum, Bavanisha ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; IMIPRAMINE;

ADULT; ANXIETY DISORDER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; JOB PERFORMANCE; NAUSEA; PRIORITY JOURNAL; SOCIAL PHOBIA; UNSPECIFIED SIDE EFFECT;

EID: 37049024489     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900015534     Document Type: Article

References (58)

1. Clark DM, McManus F. Information processing in social phobia. Biol Psychiatry. 2002;51:92-100.
2. Rapee RM, Spence SH. The etiology of social phobia: empirical evidence and an initial model. Clin Psychol Rev. 2004;24:737-767.
3. Amir N, Elias J, Klumpp H, Przeworski A. Attentional bias to threat in social phobia: facilitated processing of threat or difficulty disengaging attention from threat? Behav Res Ther. 2003;41:1325-1335.
4. Foa EB, Gilboa-Schechtman E, Amir N, Freshman M. Memory bias in generalized social phobia: remembering negative emotional expressions. J Anxiety Disord. 2000;14:501-519.
5. Stopa L, Clark DM. Social phobia and interpretation of social events. Behav Res Ther. 2000;38:273-283.
6. Rapee RM, Abbott MJ. Mental representation of observable attributes in people with social phobia. J Behav Ther Exp Psychiatry. 2006;37:113-126.
7. Stein MB, Goldin PR, Sareen J, Zorrilla LT, Brown GG. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry. 2002;59:1027-1034.
8. Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164:1476-1488.
9. Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME. Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry. 2006;59:424-429.
10. Van der Linden G, van Heerden B, Warwick J, et al. Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24:419-438.
11. Furmark T, Tillfors M, Marteinsdottir I, et al. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry. 2002;59:425-433.
12. Furmark T, Appel L, Michelgård A, et al. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry. 2005;58:132-142.
13. Warwick JM, Carey P, Van der Linden G, et al. A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder. Metab Brain Dis. 2006;21(2-3):241-252.
14. Lanzenberger RR, Mitterhauser M, Spindelegger C, et al. Reduced serotonin-1 A receptor binding in social anxiety disorder. Biol Psychiatry. 2007;61:1081-1089.
15. Furmark T, Tillfors M, Garpenstrand H, et al. Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett. 2004;362:189-192.
16. Stein MB, Seedat S, Gelernter J. Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology (Berl). 2006;187:68-72.
17. Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry. 2000;157:467-459.
18. Tiihonen J, Kuikka J, Bergström K, Lepola U, Koponen H, Leinonen E. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry. 1997;154:239-242.
19. Stein DJ, Westenberg HG, Liebowitz MR. Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry. 2002;63(suppl 6):12-19.
20. Sareen J, Campbell DW, Leslie WD, et al. Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry. 2007;61:396-404.
21. Phan KL, Fitzgerald DA, Cortese BM, Seraji-Bozorgzad N, Tancer ME, Moore GJ. Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla. Neuroreport. 2005;16:183-186.
22. Kirsch P, Esslinger C, Chen Q, et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005;25:11489-11493.
23. Prather MD, Lavenex P, Mauldin-Jourdain ML, et al. Increased social fear and decreased fear of objects in monkeys with neonatal amygdala lesions. Neuroscience. 2001;106:653-658.
24. Eisenberger NI, Lieberman MD, Williams KD. Does rejection hurt? An FMRI study of social exclusion. Science. 2003;302:290-292.
25. Stein MB. Neurobiological perspectives on social phobia: from affiliation to zoology. Biol Psychiatry. 1998;44:1277-1285.
26. Van Ameringen M, Mancini C, Farvolden P, Oakman J. The neurobiology of social phobia: from pharmacotherapy to brain imaging. Curr Psychiatry Bep. 2000;2:358-366.
27. Stein MB, Gelernter J, Smoller JW. Genetic aspects of social anxiety and related traits. In: Bandelow B, Stein DJ, eds. Social Anxiety Disorder. More than Shyness. New York, NY: Marcel Dekker, Inc.; 2004:197-214.
28. Arbelle S, Benjamin J, Golin M, Kremer I, Belmaker RH, Ebstein RP. Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. Am J Psychiatry. 2003;160:671-676.
29. Battaglia M, Ogliari A, Zanoni A, et al. Influence of the serotonin transporter promoter gene and shyness on children's cerebral responses to facial expressions. Arch Gen Psychiatry. 2005;62:85-94.
30. Smoller JW, Rosenbaum JF, Biederman J, et al. Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol Psychiatry. 2003;54:1376-1381.
31. Stein MB, Schork NJ, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology. 2007 Apr 25; [Epub ahead of print].
32. Rosenbaum JF, Biederman J, Bolduc-Murphy EA, et al. Behavioral inhibition in childhood: a risk factor for anxiety disorders. Harv Rev Psychiatry. 1993;1:2-16.
33. Schwartz CE, Wright CI, Shin LM, Kagan J, Rauch SL. Inhibited and uninhibited infants "grown up": adult amygdalar response to novelty. Science. 2003;300:1952-1953.
34. Guyer AE, Nelson EE, Perez-Edgar K, et al. Striatal functional alteration in adolescents characterized by early childhood behavioral inhibition. J Neurosci. 2006;26:6399-6405.
35. Fox NA, Nichols KE, Henderson HA, et al. Evidence for a gene-environment interaction in predicting behavioral inhibition in middle childhood. Psychol Sci. 2005;16:921-926.
36. Stein DJ, Bouwer C. Blushing and social phobia: a neuroethological speculation. Med Hypotheses. 1997;49:101-108.
37. Darwin C. The Expression of Emotion in Man and Animals. London, UK: John Murray; 1872.
38. Leary MR, Britt TW, Cutlip WD 2nd, Templeton JL. Social blushing. Psychol Bull. 1992;112:446-460.
39. Muller JE, Koen L, Stein DJ. The spectrum of social anxiety disorders. In: Bandelow B, Stein DJ, eds. Social Anxiety Disorder. New York, NY: Marcel Dekker; 2004:19-34
40. Schneier FR, Blanco C, Antia SX, Liebowitz MR. The social anxiety spectrum. Psychiatr Clin North Am. 2002;25:757-774.
41. Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J Anxiety Disord. 2002;16:661-673.
42. Connor KM, Davidson JR, Churchill LE, Sherwood A, Foa E, Weisler RH. Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br J Psychiatry. 2000;176:379-386.
43. Connor KM, Kobak KA, Churchill LE, Katzelnick D, Davidson JR. Mini-SPIN: a brief screening assessment for generalized social anxiety disorder. Depress Anxiety. 2001;14:137-140.
44. Fehm L, Pelissolo A, Furmark T, Wittchen HU. Size and burden of social phobia in Europe. Eur Neuropsychopharmacol. 2005;15:453-462.
45. Heimberg RG, Stein MB, Hiripi E, Kessler RC. Trends in the prevalence of social phobia in the United States: a synthetic cohort analysis of changes over four decades. Eur Psychiatry. 2000;15:29-37.
46. Stein DJ, Ipser JC, Balkom AJ. Pharmacotherapy for social phobia. Cochrane Database Syst Rev. 2004;(4):CD001206.
47. Blanco C, Schneier FR, Schmidt A, et al. Pharmacological treatment of social anxiety disorder: a meta-analysis. Depress Anxiety. 2003;18:29-40.
48. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005;19:567-596.
49. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry. 2002;3:171-199.
50. Swinson RP, Antony MM, Bleau PB, et al. Clinical practice guidelines: management of anxiety disorders. Can J Psychiatry. 2006;51(suppl 2):1S-92S.
51. Fedoroff IC, Taylor S. Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol. 2001;21:311-324.
52. Chavira DA, Stein MB. Childhood social anxiety disorder: from understanding to treatment. Child Adolesc Psychiatr Clin N Am. 2005;14:797-818.
53. Rapee RM, Kennedy S, Ingram M, Edwards S, Sweeney L. Prevention and Early Intervention of Anxiety Disorders in Inhibited Preschool Children. J Consult Clin Psychol. 2005;73:488-497.
54. Wakefield JC, Horwitz AV, Schmitz MF. Are we overpathologizing the socially anxious? Social phobia from a harmful dysfunction perspective. Can J Psychiatry. 2005;50:317-319.
55. Moynihan R, Smith R. Too much medicine? BMJ. 2002;324:859-860.
56. Davidson JR, Hughes DL, George LK, Blazer DG. The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychological Med. 1993;23:709-718.
57. Veit R, Flor H, Erb M, et al. Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neurosci Lett. 2002;328:233-236.
58. Meyer-Lindenberg A, Hariri AR, Munoz KE, et al. Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci. 2005;8:991-993.